Voyageur Pharmaceuticals (CVE:VM) Shares Up 21.2% – Time to Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) was up 21.2% during mid-day trading on Thursday . The company traded as high as C$0.21 and last traded at C$0.20. Approximately 292,294 shares traded hands during trading, a decline of 46% from the average daily volume of 538,273 shares. The stock had previously closed at C$0.17.

Voyageur Pharmaceuticals Stock Up 21.2 %

The stock has a market capitalization of C$27.89 million, a PE ratio of -20.00 and a beta of 0.32. The firm’s fifty day moving average is C$0.10 and its 200-day moving average is C$0.07. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Read More

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.